APPLIED MOLECULAR TRANSPORT (AMTI) Stock Price, Quote, News and Overview
NASDAQ:AMTI - Nasdaq - US03824M1099 - Common Stock - Currency: USD
AMTI Quote, Performance and Key Statistics
0.263
-0.04 (-14.3%)
The current stock price of AMTI is 0.263 USD. In the past month the price increased by 57.01%. In the past year, price decreased by -37.38%.
AMTI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About AMTI
Company Profile
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company is headquartered in Wilmington, Delaware and currently employs 79 full-time employees. The company went IPO on 2020-06-05. The firm is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company’s pipeline includes AMT-101, and AMT-126. AMT-101 is a gastrointestinal-selective oral fusion of interleukin 10 (IL-10) and its proprietary carrier molecule that has been designed for active transport across the intestinal epithelium (IE) barrier into local gastrointestinal (GI) tissue. AMT-126 is a GI-selective oral fusion of interleukin 22 (IL-22) and its proprietary carrier molecule presently in development for diseases related to IE barrier function defects. Its technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics with development-stage drugs.
Company Info
APPLIED MOLECULAR TRANSPORT
C/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange St
Wilmington DELAWARE 94080 US
CEO: Tahir Mahmood
Employees: 79
Company Website: https://www.appliedmt.com/company/
Phone: 16503920420
APPLIED MOLECULAR TRANSPORT / AMTI FAQ
What is the stock price of APPLIED MOLECULAR TRANSPORT today?
The current stock price of AMTI is 0.263 USD. The price decreased by -14.3% in the last trading session.
What is the ticker symbol for APPLIED MOLECULAR TRANSPORT stock?
The exchange symbol of APPLIED MOLECULAR TRANSPORT is AMTI and it is listed on the Nasdaq exchange.
On which exchange is AMTI stock listed?
AMTI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APPLIED MOLECULAR TRANSPORT stock?
6 analysts have analysed AMTI and the average price target is 1.02 USD. This implies a price increase of 287.83% is expected in the next year compared to the current price of 0.263. Check the APPLIED MOLECULAR TRANSPORT stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APPLIED MOLECULAR TRANSPORT worth?
APPLIED MOLECULAR TRANSPORT (AMTI) has a market capitalization of 11.01M USD. This makes AMTI a Nano Cap stock.
How many employees does APPLIED MOLECULAR TRANSPORT have?
APPLIED MOLECULAR TRANSPORT (AMTI) currently has 79 employees.
What are the support and resistance levels for APPLIED MOLECULAR TRANSPORT (AMTI) stock?
APPLIED MOLECULAR TRANSPORT (AMTI) has a support level at 0.18. Check the full technical report for a detailed analysis of AMTI support and resistance levels.
Should I buy APPLIED MOLECULAR TRANSPORT (AMTI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMTI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMTI, evaluating the profitability, health, valuation and growth aspects
- APPLIED MOLECULAR TRANSPORT (AMTI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APPLIED MOLECULAR TRANSPORT (AMTI) Sales and EPS estimates to see what analysts future expectations are.
- APPLIED MOLECULAR TRANSPORT (AMTI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APPLIED MOLECULAR TRANSPORT (AMTI) Insider and Institutional Ownership to learn about the owners and their transactions.
- APPLIED MOLECULAR TRANSPORT (AMTI) Stock Chart to make your own analysis
- APPLIED MOLECULAR TRANSPORT (AMTI) Latest news and press-releases to stay up to date.
Does APPLIED MOLECULAR TRANSPORT (AMTI) stock pay dividends?
AMTI does not pay a dividend.
When does APPLIED MOLECULAR TRANSPORT (AMTI) report earnings?
APPLIED MOLECULAR TRANSPORT (AMTI) will report earnings on 2024-03-07, after the market close.
What is the Price/Earnings (PE) ratio of APPLIED MOLECULAR TRANSPORT (AMTI)?
APPLIED MOLECULAR TRANSPORT (AMTI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.9).
AMTI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to AMTI. When comparing the yearly performance of all stocks, AMTI is one of the better performing stocks in the market, outperforming 77.29% of all stocks.
AMTI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMTI. While AMTI seems to be doing ok healthwise, there are quite some concerns on its profitability.
AMTI Financial Highlights
Over the last trailing twelve months AMTI reported a non-GAAP Earnings per Share(EPS) of -1.9. The EPS increased by 45.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -373.95% | ||
| ROE | -461.67% | ||
| Debt/Equity | 0 |
AMTI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to AMTI. The Buy consensus is the average rating of analysts ratings from 6 analysts.